Litmus Health Uses Wearables To Collect Patient Data For Clinical Trials

Healthcare startups that function as contract research organizations to validate health tech for payers, health systems and pharmaceutical companies are an emerging trend. But one company that’s providing a different approach in this category is Litmus Health. The company uses data from wearables and other devices to support Phase 1 and Phase 2 clinical trials for pharmaceutical companies and other institutions.

This week, Litmus Health launched its public beta, according to a news release.

The advantage of the company’s approach is that wearables and other connected devices are already in the hands of consumers, said Litmus CEO Daphne Kis in the release.

Back to news